Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection

NCT01910636 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Sofosbuvir
DRUG: RBV

Sponsor

Gilead Sciences